891 related articles for article (PubMed ID: 23477881)
1. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
2. Pre-market clinical evaluations of innovative high-risk medical devices in Europe.
Hulstaert F; Neyt M; Vinck I; Stordeur S; Huić M; Sauerland S; Kuijpers MR; Abrishami P; Vondeling H; Flamion B; Garattini S; Pavlovic M; van Brabandt H
Int J Technol Assess Health Care; 2012 Jul; 28(3):278-84. PubMed ID: 22980705
[TBL] [Abstract][Full Text] [Related]
3. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
Campillo-Artero C
Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
[TBL] [Abstract][Full Text] [Related]
4. Market introduction of innovative high risk medical devices: towards a recast of the directive concerning medical devices.
Vinck I; Hulstaert F; Van Brabandt H; Neyt M; Stordeur S
Eur J Health Law; 2011 Dec; 18(5):477-89. PubMed ID: 22128518
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies of innovative medical devices: what level of evidence for hospital-based health technology assessment?
Boudard A; Martelli N; Prognon P; Pineau J
J Eval Clin Pract; 2013 Aug; 19(4):697-702. PubMed ID: 23510375
[TBL] [Abstract][Full Text] [Related]
6. Regulation of medical devices in the European Union.
Chai J
J Leg Med; 2000 Dec; 21(4):537-56. PubMed ID: 11194571
[No Abstract] [Full Text] [Related]
7. Health technology assessment for medical devices in Europe. What must be considered.
Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
[TBL] [Abstract][Full Text] [Related]
8. Notified Body guidance on clinical evaluation.
Donawa M
Med Device Technol; 2000 Sep; 11(7):26-8. PubMed ID: 15326742
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
Fraser AG; Daubert JC; Van de Werf F; Estes NA; Smith SC; Krucoff MW; Vardas PE; Komajda M;
Eur Heart J; 2011 Jul; 32(13):1673-86. PubMed ID: 21572115
[TBL] [Abstract][Full Text] [Related]
10. Standards for humidification and filtration devices.
Stevens J
Respir Care Clin N Am; 2006 Jun; 12(2):203-32. PubMed ID: 16828691
[TBL] [Abstract][Full Text] [Related]
11. Technology assessment of medical devices at the Center for Devices and Radiological Health.
Kessler L; Richter K
Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
[TBL] [Abstract][Full Text] [Related]
12. The need for transparency of clinical evidence for medical devices in Europe.
Fraser AG; Butchart EG; Szymański P; Caiani EG; Crosby S; Kearney P; Van de Werf F
Lancet; 2018 Aug; 392(10146):521-530. PubMed ID: 30017550
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluations clinical investigations under the amended Medical Device Directive.
Dannhorn DR; Schwabedissen H
Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
[TBL] [Abstract][Full Text] [Related]
14. [Data transparency regarding medical devices - the position of the medical device industry].
Soskuty G
Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):189-93. PubMed ID: 21530908
[TBL] [Abstract][Full Text] [Related]
15. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
18. Medical devices: marketing authorisations are needed.
Prescrire Int; 2012 Sep; 21(130):223. PubMed ID: 23016262
[No Abstract] [Full Text] [Related]
19. New developments in clinical testing of medical devices for Europe 1992.
Reneman RS
Eur J Cardiothorac Surg; 1992; 6 Suppl 1():S102-6. PubMed ID: 1389268
[TBL] [Abstract][Full Text] [Related]
20. European legislation of biomedical technology.
Mambretti C
Ann Ist Super Sanita; 1995; 31(1):109-12. PubMed ID: 8546358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
